How should I approach a 38-year-old woman presenting with headaches that begin at the start of her menstrual period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Approach to Menstrual-Related Headache in a 38-Year-Old Woman

For a 38-year-old woman with headaches starting at menses, first confirm this is menstrual migraine through a 3-month headache diary documenting attacks occurring from 2 days before through day 3 of menstruation, then treat acute attacks with combination therapy (triptan + NSAID), and if attacks persist or are severe, initiate perimenstrual prophylaxis with frovatriptan 2.5 mg twice daily or naproxen starting 2 days before expected menses for 5 days. 1, 2

Step 1: Establish the Diagnosis

Document the Pattern

  • Have the patient maintain a 3-month headache diary to confirm the temporal relationship between headaches and menstruation 3, 1
  • Menstrual migraine is defined as attacks occurring predictably from 2 days before menstruation through the first 3 days of bleeding 1, 4
  • Approximately 8% of women have pure menstrual migraine (attacks exclusively during menstruation), while others have menstrually-related migraine with additional attacks at other times 1

Key History Elements to Obtain

Ask specifically about 3:

  • Character of pain: throbbing, unilateral location
  • Associated symptoms: nausea, vomiting, photophobia, phonophobia
  • Presence or absence of aura (visual disturbances, sensory changes)
  • Duration: typically hours to days
  • Severity and functional disability: menstrual attacks are characteristically more severe, longer-lasting, and more disabling than non-menstrual attacks 4, 5
  • Response to prior treatments: over-the-counter medications, prescription drugs
  • Family history of migraine
  • Other menstrual symptoms: dysmenorrhea, menorrhagia, irregular cycles

Rule Out Red Flags

Do NOT perform neuroimaging unless red flags are present 3:

  • Rapidly increasing headache frequency
  • Focal neurologic signs or symptoms
  • Headache awakening patient from sleep
  • Thunderclap onset
  • Marked change in headache pattern
  • Persistent headache after head trauma
  • Atypical features inconsistent with migraine

Important caveat: Not all menstruation-associated headaches are migraine. Consider paroxysmal hemicrania if attacks are very short (5-20 minutes), occur multiple times daily, and have prominent autonomic features (tearing, nasal congestion, restlessness) 6

Step 2: Acute Treatment Strategy

First-Line Acute Therapy

Start with combination therapy for moderate-to-severe attacks 2:

  • Triptan + NSAID (e.g., sumatriptan 50-100 mg + naproxen 500 mg)
  • This combination is superior to either agent alone
  • Counsel patient to take medication as early as possible after headache onset to maximize efficacy 2

Alternative Acute Options

For mild attacks 2:

  • NSAID alone (ibuprofen, naproxen, diclofenac)
  • Acetaminophen (less effective than NSAIDs)
  • NSAID + acetaminophen combination

If combination therapy fails 2:

  • Try different triptans (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, zolmitriptan) - patients may respond to one triptan but not another
  • Consider CGRP antagonists (rimegepant, ubrogepant, zavegepant)
  • Non-oral triptan (sumatriptan subcutaneous) if severe nausea/vomiting present 2

Critical Warnings

  • NEVER use opioids or butalbital for migraine treatment 2
  • Monitor for medication overuse headache: ≥10 days/month triptan use or ≥15 days/month NSAID use can cause rebound headaches 2, 3

Step 3: Perimenstrual Prophylaxis (If Acute Treatment Insufficient)

Menstrual attacks are notoriously more severe and treatment-resistant than non-menstrual attacks 7, 4, 5. The predictable timing allows for targeted short-term prevention.

Evidence-Based Perimenstrual Prophylaxis Options

Initiate prophylaxis 2 days before expected menstruation and continue for 5 days 1:

First choice - Triptans (Grade B evidence) 1, 4:

  • Frovatriptan 2.5 mg twice daily
  • Naratriptan 1 mg twice daily
  • These long-acting triptans have proven efficacy for perimenstrual prophylaxis

Alternative - NSAIDs 1:

  • Naproxen 500 mg twice daily (or other long-acting NSAID)
  • Particularly useful if patient has comorbid dysmenorrhea 7
  • Allows use of triptans for breakthrough headaches

When to Consider Long-Term Prevention

If patient has 3:

  • More than 2 headaches per week (including non-menstrual attacks)
  • Frequent episodic migraine requiring preventive medication
  • Inadequate response to perimenstrual prophylaxis

Long-term preventive options 1, 8:

  • First-line: Propranolol, metoprolol, topiramate, candesartan
  • Second-line: Amitriptyline, flunarizine
  • Third-line: CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab), onabotulinumtoxinA

Step 4: Hormonal Strategies (For Women Needing Contraception)

Combined Hormonal Contraceptives

For women with pure menstrual migraine WITHOUT aura 1:

  • Consider continuous or extended-cycle combined hormonal contraceptives (no hormone-free interval)
  • This eliminates the estrogen withdrawal that triggers menstrual migraine
  • Treats comorbid conditions: dysmenorrhea, menorrhagia, endometriosis, irregular cycles 7

Critical Contraindication

Combined hormonal contraceptives are ABSOLUTELY CONTRAINDICATED in women with migraine with aura due to increased stroke risk 1

Alternative Hormonal Approach

  • Transdermal estradiol 1.5 mg applied perimenstrually (Grade B evidence) 4
  • Prevents the premenstrual estrogen decline that precipitates attacks

Step 5: Lifestyle Modifications and Patient Education

Essential Counseling Points 2

  • Hydration: maintain adequate fluid intake
  • Regular meals: avoid skipping meals
  • Sleep hygiene: consistent sleep schedule, 7-8 hours nightly
  • Regular aerobic exercise: moderate to intense physical activity
  • Stress management: relaxation techniques, mindfulness
  • Weight management if overweight/obese

Set Realistic Expectations 1

  • Migraine is not curable but is controllable
  • Goal is to reduce attack frequency, severity, and duration to minimize disability
  • Treatment success means regaining control from the disease, not complete elimination of all headaches

Step 6: Follow-Up and Monitoring

  • Reassess in 2-3 months after initiating or changing treatment 1
  • Continue headache diary to track:
    • Attack frequency (migraine days per month)
    • Attack severity and duration
    • Functional disability
    • Acute medication use (to monitor for overuse)
  • Adjust treatment based on response

When Treatment Fails

  • Verify diagnosis is correct
  • Confirm medication adherence and proper use
  • Check for medication overuse headache
  • Consider switching within drug class (different triptan, different NSAID)
  • Escalate to next treatment tier

Special Considerations for This 38-Year-Old Patient

Reproductive Planning

  • If pregnancy is planned or possible, discuss medication safety 2, 8
  • Migraine often improves during pregnancy, especially after first trimester
  • Safest acute options in pregnancy: acetaminophen, limited triptan use (emerging evidence suggests may be safer than previously thought) 5
  • Avoid topiramate and valproate in women of childbearing potential (teratogenic) 1, 8

Age-Appropriate Counseling

  • At 38, patient is in peak years for menstrual migraine prevalence
  • After age 45, the gender difference in migraine prevalence decreases 9
  • Perimenopausal transition may alter migraine patterns in coming years

This algorithmic approach prioritizes the most recent high-quality guidelines 1, 2 while incorporating specific evidence for menstrual migraine management 4. The stepped approach ensures appropriate escalation from acute treatment to prophylaxis based on treatment response and attack severity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.